Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/TANGO-THERAPEUTICS-INC-111641934/news/Tango-Therapeutics-Announces-First-Patient-Dosed-in-TNG462-Phase-1-2-Trial-in-Patients-with-MTAP-Del-44302845/?utm_source=whatsapp&utm_medium=social&utm_campaign=share